Literature DB >> 7028080

Reactivity of monoclonal antibodies with human myeloid precursor cells.

D H Crawford, G E Francis, M A Wing, A J Edwards, G Janossy, A V Hoffbrand, H G Prentice, D Secher, I McConnell, P C Kung, G Goldstein.   

Abstract

Five monoclonal antibodies have been tested for their ability to bind to myeloid precursor cells in normal human bone marrow. Indirect immunofluorescence and the fluorescence activated cell sorter was used to separate cells according to their reactivity for trial culture in vitro in order to grow granulocyte-macrophage colony forming cells (CFUc). Two antibodies (OKT3 and OKT11) which react strongly with bone marrow T lymphocytes were found to be unreactive with CFUc. YD1/23 reacts very strongly with both T and B lymphocytes but is only weakly reactive with CFUc. In contrast, OKT10 and YE2/36 did react with CFUc. The consequences of these findings and the potential clinical use of these antibodies in bone marrow transplantation are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028080     DOI: 10.1111/j.1365-2141.1981.tb07217.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  A mature thymocyte-like phenotypic pattern on human cord circulating T-lymphoid cells.

Authors:  R Gerli; P Rambotti; C Cernetti; A Velardi; F Spinozzi; A Tabilio; M F Martelli; F Grignani; S Davis
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

2.  Monoclonal antibodies against differentiation antigens of myelopoiesis.

Authors:  W Knapp
Journal:  Blut       Date:  1982-11

Review 3.  Immunotherapies targeting CD38 in Multiple Myeloma.

Authors:  Djordje Atanackovic; Mary Steinbach; Sabarinath Venniyil Radhakrishnan; Tim Luetkens
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.